NET-smart chemotherapy: a targeted prodrug strategy
Justin Annes, MD, PhD
Funded Research Projects
Understanding the physiologically relevant functions of DAXX
Guillermina (Gigi) Lozano, PhD
Multipronged approaches to develop immunotherapy targeting NETs
Xianxin Hua, MD, PhD
New strategies to improve drug development for carcinoid tumors
Emily Bergsland, MD
Intra-arterial Peptide Receptor Radionuclide Therapy (IA-PRRT) using 90Y-DOTA-TOC
Thomas Hope, MD
Targeting the Alternative Lengthening of Telomere (ALT) pathway in pancreatic NETs
Christopher Heaphy, PhD
Octreotide-targeted treatment of pancreatic NETs
Renata Pasqualini, PhD
Treating neuroendocrine tumors via synthetic lethality
Michael German, MD
Finding the causes of small intestinal neuroendocrine tumors
Matthew Meyerson, MD, PhD; Eric Nakakura, MD, PhD; Chrissie Thirlwell, MD, PhD
Mutational landscape of pancreatic NETs - Using the “liquid biopsy” to study genetic evolution over time and through therapy
Nitya Raj, MD; Diane Reidy-Lagunes, MD